invesco ltd. - IVZ
IVZ
Close Chg Chg %
22.44 -0.08 -0.33%
Closed Market
22.37
-0.08 (0.33%)
Volume: 3.89M
Last Updated:
Sep 15, 2025, 3:59 PM EDT
Company Overview: invesco ltd. - IVZ
IVZ Key Data
| Open $22.49 | Day Range 22.31 - 22.73 |
| 52 Week Range 11.60 - 22.78 | Market Cap $10.00B |
| Shares Outstanding 445.96M | Public Float 442.39M |
| Beta 1.56 | Rev. Per Employee N/A |
| P/E Ratio 24.09 | EPS $0.93 |
| Yield 370.04% | Dividend $0.21 |
| EX-DIVIDEND DATE Aug 14, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 3.72M |
IVZ Performance
| 1 Week | 0.00% | ||
| 1 Month | 6.20% | ||
| 3 Months | 54.37% | ||
| 1 Year | 40.10% | ||
| 5 Years | 104.28% |
IVZ Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
15
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 23.25 | |
| Number of Ratings | 15 | Current Quarters Estimate | 0.465 | |
| FY Report Date | 09 / 2025 | Current Year's Estimate | 1.797 | |
| Last Quarter’s Earnings | 0.36 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.71 | Next Fiscal Year Estimate | 2.274 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 11 | 11 | 13 | 13 |
| Mean Estimate | 0.47 | 0.52 | 1.80 | 2.27 |
| High Estimates | 0.51 | 0.56 | 1.87 | 2.45 |
| Low Estimate | 0.39 | 0.48 | 1.73 | 2.04 |
| Coefficient of Variance | 6.85 | 4.54 | 2.62 | 5.75 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 1 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 12 | 12 | 13 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 1 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Invesco Ltd. - IVZ
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Invesco Ltd. - IVZ
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| May 20, 2025 | Thomas P. Gibbons Director | 39,090 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | William Francis Glavin Director | 72,972 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | G. Richard Wagoner Director | 99,758 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Phoebe A. Wood Director | 101,999 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Christopher C. Womack Director | 51,805 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Thomas Michael Finke Director | 56,126 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Sarah Jones Beshar Director | 107,035 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Nigel Elton Sheinwald Director | 93,856 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Elizabeth S. Johnson Director | 40,658 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Paula C. Tolliver Director | 58,161 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 17, 2025 | Douglas James Sharp Senior Managing Director | 139,047 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jan 17, 2025 | Douglas James Sharp Senior Managing Director | 125,328 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $17.05 per share | 2,136,842.40 |
| Jan 17, 2025 | Douglas James Sharp Senior Managing Director | 87,566 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Invesco Ltd. in the News
Democratic tax proposal takes aim at ETFs
A top Senate Democrat has been circulating a proposal that would hit the rapidly growing world of exchange-traded funds. Big money managers are bracing for a fight.